We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+35.33%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$6.37B
AUM Growth
+$1.59B
Cap. Flow
+$68.6M
Cap. Flow %
1.08%
Top 10 Hldgs %
25.07%
Holding
153
New
16
Increased
66
Reduced
51
Closed
5

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$50.1M
2
VEEV icon
Veeva Systems
VEEV
+$41.3M
3
CHGG icon
Chegg
CHGG
+$24M
4
AYI icon
Acuity Brands
AYI
+$18.1M
5
EVH icon
Evolent Health
EVH
+$16.9M

Sector Composition

Rank Sector Weight
1 Technology 35.27%
2 Healthcare 21.17%
3 Industrials 16.56%
4 Consumer Discretionary 8.92%
5 Consumer Staples 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLOB icon
1
Globant
GLOB
$1.63B
$212M 3.32%
1,412,406
+8,131
+0.6% +$1M
PRLB icon
2
Protolabs
PRLB
$1.72B
$171M 2.69%
1,524,498
+17,376
+1% +$1.78M
CSGP icon
3
CoStar Group
CSGP
$12B
$171M 2.69%
2,412,370
-72,670
-3% -$4.7M
LOPE icon
4
Grand Canyon Education
LOPE
$4.16B
$159M 2.5%
1,759,186
+33,691
+2% +$3M
BL icon
5
BlackLine
BL
$1.93B
$157M 2.46%
1,889,833
+6,452
+0.3% +$431K
CHE icon
6
Chemed
CHE
$7.17B
$152M 2.38%
336,362
-28,503
-8% -$12.7M
MSFT icon
7
Microsoft
MSFT
$2.94T
$147M 2.3%
720,662
+8,014
+1% +$1.45M
TYL icon
8
Tyler Technologies
TYL
$14.1B
$146M 2.29%
420,630
+14,399
+4% +$4.83M
RBA icon
9
RB Global
RBA
$21.5B
$143M 2.25%
3,508,541
+42,206
+1% +$1.73M
FIVE icon
10
Five Below
FIVE
$11.7B
$139M 2.19%
1,303,692
+7,134
+0.6% +$669K
WST icon
11
West Pharmaceutical
WST
$23.5B
$138M 2.16%
605,681
+21,679
+4% +$4.26M
VRSK icon
12
Verisk Analytics
VRSK
$28.7B
$136M 2.14%
800,074
+21,098
+3% +$3.33M
FAST icon
13
Fastenal
FAST
$54.5B
$135M 2.12%
6,310,318
+227,608
+4% +$4.35M
AMED
14
DELISTED
Amedisys
AMED
$133M 2.09%
672,069
+11,328
+2% +$2.11M
ANSS
15
DELISTED
Ansys
ANSS
$132M 2.07%
452,351
+12,713
+3% +$3.39M
PEGA icon
16
Pegasystems
PEGA
$5.06B
$123M 1.93%
2,431,622
-8,978
-0.4% -$389K
TDOC icon
17
Teladoc Health
TDOC
$1.69B
$119M 1.87%
623,555
-286,127
-31% -$50.1M
VEEV icon
18
Veeva Systems
VEEV
$33.8B
$118M 1.85%
502,514
-208,415
-29% -$41.3M
PAYC icon
19
Paycom
PAYC
$7.95B
$117M 1.83%
376,787
+13,629
+4% +$3.63M
HEI icon
20
HEICO Corp
HEI
$49.5B
$110M 1.73%
1,103,552
+90,489
+9% +$8.35M
ALRM icon
21
Alarm.com
ALRM
$2.74B
$108M 1.7%
1,668,717
-10,287
-0.6% -$518K
HCSG icon
22
Healthcare Services Group
HCSG
$1.58B
$104M 1.62%
4,231,582
+632,557
+18% +$15M
NATI
23
DELISTED
National Instruments Corp
NATI
$102M 1.61%
2,643,828
+40,356
+2% +$1.53M
TECH icon
24
Bio-Techne
TECH
$11.2B
$102M 1.61%
1,549,996
+10,744
+0.7% +$643K
NEOG icon
25
Neogen
NEOG
$1.99B
$97.2M 1.53%
2,505,494
+34,970
+1% +$1.18M

Similar funds

Riverbridge Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Riverbridge Partners held 153 positions worth $6.37B, up 33% from $4.78B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Riverbridge Partners's Q2 2020 filing shows 16 new, 66 increased, 51 reduced and 5 closed positions. Its largest new stake was Align Technology: 119,957 shares worth $32.9M. The largest sale was Teladoc Health, an estimated $50.1M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.

  • Riverbridge Partners's largest Q2 2020 buy was Align Technology: 119,957 shares worth $32.9M.
  • Riverbridge Partners added most to Workiva in Q2 2020, an estimated $19.9M increase.
  • Riverbridge Partners's biggest Q2 2020 reduction was Teladoc Health, cutting an estimated $50.1M.
  • Riverbridge Partners fully exited Acuity Brands in Q2 2020, selling an estimated $18.1M.
  • Riverbridge Partners's ten largest holdings make up 25% of its $6.37B portfolio in Q2 2020.
  • Riverbridge Partners opened 16 new positions and closed 5 in Q2 2020.
  • Riverbridge Partners's portfolio value rose 33% quarter-over-quarter to $6.37B.

Based on Riverbridge Partners's 13F filing for Q2 2020, filed 8 Jul 2020.